Berlin: Bayer has announced the submission of marketing authorization applications to the U.S. Food and Drug Administration ...
EET Orion’s collaboration partner Bayer submits application in China for third indication of darolutamide Orion’s collaboration partner Bayer has submitted an application to the Center of Drug ...
Orion's collaboration partner Bayer has submitted an application to the Center of Drug Evaluation (CDE) of China's National ...
The German pharmaceutical company will work with One Drop on digital health products that span multiple therapeutic areas, with Bayer citing oncology, cardiovascular diseases and women’s health ...
Bayer seeks China NMPA marketing authorization for ARi darolutamide in combo with ADT in patients with metastatic hormone-sensitive prostate cancer: Berlin Wednesday, January 8, 2 ...
Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies ...
Bayer's two-year-old digital health collaboration ... has been working with New York-based One Drop on digital health products that span multiple therapeutic areas, including oncology and women's ...
EET Orion's collaboration partner Bayer submits application in China for third indication of darolutamide Orion's collaboration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback